# DCM User Journey: Complete UX Flow for POC
## Creating the "Oncology ctDNA Outcomes" Collection

**Date:** November 11, 2025
**Persona:** Divya (Data Collection Manager)
**Scenario:** Creating a curated collection for oncology researchers studying ctDNA biomarkers and immunotherapy
**Estimated Time:** 30-45 minutes for experienced DCM

---

## Phase 1: Identify Need & Express Intent

**Entry Point:** Divya opens DCM Portal â†’ Clicks **"Create New Collection"**

### UI Screen: Intent Input

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                     Create New Collection                        â”‚
â”‚â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”‚
â”‚                                                                  â”‚
â”‚  Tell us what you're looking for:                               â”‚
â”‚                                                                  â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”â”‚
â”‚  â”‚ I need to create a collection for oncology researchers     â”‚â”‚
â”‚  â”‚ studying ctDNA biomarkers and immunotherapy response in    â”‚â”‚
â”‚  â”‚ lung cancer patients                                       â”‚â”‚
â”‚  â”‚                                                             â”‚â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜â”‚
â”‚                                                                  â”‚
â”‚  ğŸ’¡ Tip: Describe your collection's purpose, target therapeutic â”‚
â”‚     area, data types, or research focus. Our AI will suggest   â”‚
â”‚     relevant data categories to help you get started.          â”‚
â”‚                                                                  â”‚
â”‚  [Cancel]                          [Get AI Suggestions â†’]       â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

**User Action:** Types intent text â†’ Clicks **[Get AI Suggestions]**

---

## Phase 2: AI-Assisted Category Suggestion

### UI Screen: Category Suggestions

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                AI-Suggested Data Categories                      â”‚
â”‚â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”‚
â”‚                                                                  â”‚
â”‚  Based on your intent, we identified these keywords:            â”‚
â”‚  ğŸ·ï¸ oncology  ğŸ·ï¸ ctDNA  ğŸ·ï¸ biomarkers  ğŸ·ï¸ immunotherapy      â”‚
â”‚  ğŸ·ï¸ lung cancer  ğŸ·ï¸ response                                   â”‚
â”‚                                                                  â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€ â”‚
â”‚                                                                  â”‚
â”‚  Recommended Data Categories:                                   â”‚
â”‚                                                                  â”‚
â”‚  THERAPEUTIC AREAS                                              â”‚
â”‚  â˜‘ ONC (Oncology) - 245 studies available                      â”‚
â”‚  â˜‘ IMMUNONC (Immuno-Oncology) - 87 studies available           â”‚
â”‚                                                                  â”‚
â”‚  SDTM (Clinical Trial Standard Data)                            â”‚
â”‚  â˜‘ Demographics (AGE, SEX, RACE) - 412 studies                 â”‚
â”‚  â˜‘ Exposure (Treatment arms, dosing, duration) - 398 studies   â”‚
â”‚  â˜‘ Tumor/Response Assessment (RECIST, iRECIST, BOR) - 156      â”‚
â”‚  â˜‘ Biomarker/Laboratory Results - 287 studies                  â”‚
â”‚  â˜‘ Adverse Events (AESI, grade, causality) - 402 studies       â”‚
â”‚                                                                  â”‚
â”‚  RAW DATA (Pre-Standardization)                                 â”‚
â”‚  â˜‘ ctDNA Measures (VAF, copies/mL, tumor fraction) - 23 â­     â”‚
â”‚  â˜‘ Specimen Metadata (Aliquot IDs, volume, QC) - 45 studies    â”‚
â”‚  â˜‘ Assay Metadata (Platform, kit version) - 38 studies         â”‚
â”‚                                                                  â”‚
â”‚  ADaM (Analysis-Ready Data)                                     â”‚
â”‚  â˜‘ ADSL (Subject-Level baseline characteristics) - 389         â”‚
â”‚  â˜‘ ADRS/ADEFF (Response/Efficacy outcomes) - 234 studies       â”‚
â”‚  â˜‘ ADTTE (Time-to-Event: OS, PFS) - 198 studies                â”‚
â”‚  â˜‘ ADBM/ADLB (Biomarker/Laboratory analysis) - 67 studies      â”‚
â”‚                                                                  â”‚
â”‚  OMICS/NGS (Genomics)                                           â”‚
â”‚  â˜‘ Variants (SNVs, indels in HGVS/VCF) - 34 studies            â”‚
â”‚  â˜‘ Global Scores (TMB, MSI status, HRD) - 28 studies           â”‚
â”‚  â˜‘ QC Metrics (Coverage depth, contamination %) - 31 studies   â”‚
â”‚                                                                  â”‚
â”‚  [+ Add More Categories]  [View Full Taxonomy (30+)]            â”‚
â”‚                                                                  â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€ â”‚
â”‚                                                                  â”‚
â”‚  [â† Back]  [Select All Suggested]  [Continue with Selection â†’] â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

**User Action:** Reviews suggestions â†’ Clicks **[Continue with Selection]**

---

## Phase 3: Multi-Dimensional Dynamic Filtering

### UI Screen: Advanced Filters with Live Results

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  Refine Your Dataset Selection                                  â”‚
â”‚â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”‚
â”‚                                                                  â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”‚
â”‚  â”‚ FILTERS              â”‚  â”‚ RESULTS: 42 datasets            â”‚ â”‚
â”‚  â”‚â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”‚  â”‚â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”‚ â”‚
â”‚  â”‚                      â”‚  â”‚                                 â”‚ â”‚
â”‚  â”‚ ğŸ¯ DATA CATEGORIES   â”‚  â”‚ [Sort: Relevance â–¼] [View: âŠ] â”‚ â”‚
â”‚  â”‚ âœ“ 15 selected        â”‚  â”‚                                 â”‚ â”‚
â”‚  â”‚ [Modify Selection]   â”‚  â”‚ â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”‚ â”‚
â”‚  â”‚                      â”‚  â”‚ â”‚ DCODE-042: NSCLC ctDNA     â”‚ â”‚ â”‚
â”‚  â”‚ ğŸ¥ STUDY CHARS       â”‚  â”‚ â”‚ Monitoring - Phase III     â”‚ â”‚ â”‚
â”‚  â”‚ TA: ONC, IMMUNONC âœ“  â”‚  â”‚ â”‚                             â”‚ â”‚ â”‚
â”‚  â”‚ Phase:               â”‚  â”‚ â”‚ 890 patients | Closed 2024 â”‚ â”‚ â”‚
â”‚  â”‚  [ ] I  [ ] II       â”‚  â”‚ â”‚                             â”‚ â”‚ â”‚
â”‚  â”‚  [âœ“] III [ ] IV      â”‚  â”‚ â”‚ Categories: SDTM (5), RAW  â”‚ â”‚ â”‚
â”‚  â”‚ Status:              â”‚  â”‚ â”‚ (2), Omics (2), ADaM (4)   â”‚ â”‚ â”‚
â”‚  â”‚  [ ] Active          â”‚  â”‚ â”‚                             â”‚ â”‚ â”‚
â”‚  â”‚  [âœ“] Closed          â”‚  â”‚ â”‚ ğŸ“Š In 3 collections         â”‚ â”‚ â”‚
â”‚  â”‚ Geography:           â”‚  â”‚ â”‚ ğŸ‘¥ 87 users, 5 orgs         â”‚ â”‚ â”‚
â”‚  â”‚  [âœ“] All regions     â”‚  â”‚ â”‚                             â”‚ â”‚ â”‚
â”‚  â”‚                      â”‚  â”‚ â”‚ âš¡ 20% open | 30% ready     â”‚ â”‚ â”‚
â”‚  â”‚ ğŸ“Š COLLECTION        â”‚  â”‚ â”‚    40% needs approval       â”‚ â”‚ â”‚
â”‚  â”‚    CONTEXT           â”‚  â”‚ â”‚                             â”‚ â”‚ â”‚
â”‚  â”‚ Crossover:           â”‚  â”‚ â”‚ ğŸ’¡ Bundled with: DCODE-001 â”‚ â”‚ â”‚
â”‚  â”‚  [ ] New (0 colls)   â”‚  â”‚ â”‚    DCODE-088, DCODE-102    â”‚ â”‚ â”‚
â”‚  â”‚  [âœ“] Moderate (1-3)  â”‚  â”‚ â”‚                             â”‚ â”‚ â”‚
â”‚  â”‚  [ ] High (4+)       â”‚  â”‚ â”‚ [â˜‘ Select] [View Details]  â”‚ â”‚ â”‚
â”‚  â”‚ Usage:               â”‚  â”‚ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â”‚ â”‚
â”‚  â”‚  [âœ“] High (50+ usr)  â”‚  â”‚                                 â”‚ â”‚
â”‚  â”‚  [âœ“] Med (10-50)     â”‚  â”‚ â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”‚ â”‚
â”‚  â”‚  [ ] Low (<10)       â”‚  â”‚ â”‚ DCODE-067: Immunotherapy   â”‚ â”‚ â”‚
â”‚  â”‚                      â”‚  â”‚ â”‚ Response - Phase III        â”‚ â”‚ â”‚
â”‚  â”‚ ğŸ” ACCESS            â”‚  â”‚ â”‚ ...                         â”‚ â”‚ â”‚
â”‚  â”‚ Status:              â”‚  â”‚ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â”‚ â”‚
â”‚  â”‚  [âœ“] Some open       â”‚  â”‚                                 â”‚ â”‚
â”‚  â”‚  [âœ“] Some restricted â”‚  â”‚ [Load More Results]             â”‚ â”‚
â”‚  â”‚  [ ] All restricted  â”‚  â”‚                                 â”‚ â”‚
â”‚  â”‚ Training:            â”‚  â”‚                                 â”‚ â”‚
â”‚  â”‚  [âœ“] GCP required    â”‚  â”‚                                 â”‚ â”‚
â”‚  â”‚  [âœ“] Data Privacy L2 â”‚  â”‚                                 â”‚ â”‚
â”‚  â”‚ Legal:               â”‚  â”‚                                 â”‚ â”‚
â”‚  â”‚  [ ] GDPR only       â”‚  â”‚                                 â”‚ â”‚
â”‚  â”‚  [âœ“] None/Mixed      â”‚  â”‚                                 â”‚ â”‚
â”‚  â”‚                      â”‚  â”‚                                 â”‚ â”‚
â”‚  â”‚ [Reset Filters]      â”‚  â”‚                                 â”‚ â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â”‚
â”‚                                                                  â”‚
â”‚  [â† Back to Categories]                 [Continue with 0 â†’]     â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

**User Action:**
- Adjusts Phase filter (only Phase III checked)
- Result count updates: 42 â†’ 28 datasets
- Selects datasets by checking boxes

---

## Phase 4: Dataset Card Detail View

### UI Component: Expanded Dataset Card

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ DCODE-042: NSCLC ctDNA Monitoring - Phase III                 â”‚
â”‚â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”‚
â”‚                                                                 â”‚
â”‚ ğŸ“‹ STUDY OVERVIEW                                              â”‚
â”‚ Patients: 890 | Status: Closed 2024-03-15                     â”‚
â”‚ Therapeutic Area: Oncology - NSCLC (Non-Small Cell Lung)      â”‚
â”‚ Treatment Arms: Pembrolizumab + Chemotherapy vs Chemo alone   â”‚
â”‚                                                                 â”‚
â”‚ ğŸ“¦ DATA CATEGORIES AVAILABLE                                   â”‚
â”‚ âœ“ SDTM: Demographics, Exposure, Tumor/Response Assessment,    â”‚
â”‚         Biomarker/Laboratory Results, Adverse Events           â”‚
â”‚ âœ“ RAW: ctDNA Measures (VAF, copies/mL), Specimen Metadata     â”‚
â”‚ âœ“ Omics/NGS: Variants (SNVs, indels), Global Scores (TMB/MSI) â”‚
â”‚ âœ“ ADaM: ADSL, ADRS, ADTTE, ADBM                               â”‚
â”‚                                                                 â”‚
â”‚ ğŸ“Š COLLECTION CROSSOVER (DCM-Specific)                         â”‚
â”‚ This dataset appears in 3 collections:                         â”‚
â”‚  â€¢ Lung Cancer Phase III Studies (85 users)                   â”‚
â”‚  â€¢ Immunotherapy Response Collection (62 users)                â”‚
â”‚  â€¢ Multi-Modal Oncology Data (45 users)                        â”‚
â”‚                                                                 â”‚
â”‚ ğŸ‘¥ USAGE ANALYTICS                                             â”‚
â”‚ Active Users: 87 across 5 organizations                        â”‚
â”‚ Most Common Use: Biomarker outcome analysis, immunotherapy     â”‚
â”‚                  response prediction                            â”‚
â”‚                                                                 â”‚
â”‚ âš¡ ACCESS ELIGIBILITY (for your 120 target users)              â”‚
â”‚ â–“â–“â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘ 20% Already Open (no action needed)                â”‚
â”‚ â–“â–“â–“â–‘â–‘â–‘â–‘â–‘â–‘â–‘ 30% Ready to Grant (instant after your confirm)    â”‚
â”‚ â–“â–“â–“â–“â–‘â–‘â–‘â–‘â–‘â–‘ 40% Needs Approval (GPT-Oncology, 2-3 days)        â”‚
â”‚ â–“â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘ 10% Missing Location (data discovery needed)       â”‚
â”‚                                                                 â”‚
â”‚ ğŸ’¡ SMART SUGGESTIONS                                           â”‚
â”‚ Frequently bundled with:                                       â”‚
â”‚  â†’ DCODE-001: NSCLC Genomic Profiling (in 8 collections)      â”‚
â”‚  â†’ DCODE-088: Lung Cancer Outcomes (in 6 collections)          â”‚
â”‚  â†’ DCODE-102: PET Imaging Substudy (in 4 collections)          â”‚
â”‚                                                                 â”‚
â”‚ ğŸ·ï¸ METADATA                                                     â”‚
â”‚ Data Location: S3 (Clinical), SolveBio (Genomics)             â”‚
â”‚ Last Updated: 2024-09-12                                       â”‚
â”‚ Data Steward: Dr. Sarah Johnson (PRID: P789012)               â”‚
â”‚ Quality Score: 8.5/10 (92% complete metadata)                  â”‚
â”‚                                                                 â”‚
â”‚ [âœ“ Selected] [View Full Metadata] [Report Issue] [Remove]     â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

## Phase 5: Selection Cart with Real-Time Access Matrix

### UI Component: Floating Selection Cart (always visible)

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ YOUR COLLECTION                                          [â€”][Ã—] â”‚
â”‚â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”‚
â”‚ 15 datasets selected                              [View List â–¼]â”‚
â”‚                                                                 â”‚
â”‚ REAL-TIME ACCESS MATRIX (120 target users)                     â”‚
â”‚ â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”‚
â”‚ â”‚                                                             â”‚ â”‚
â”‚ â”‚ âœ… 60 users (50%): Immediate access to some datasets       â”‚ â”‚
â”‚ â”‚ âš¡ 108 users (90%): Instant access after your confirmation â”‚ â”‚
â”‚ â”‚ ğŸŸ¡ 108 users (90%): Access after GPT/TALT approval         â”‚ â”‚
â”‚ â”‚ â“ Varies: 2 datasets have location issues                 â”‚ â”‚
â”‚ â”‚ â³ 12 users (10%): Need training completion                â”‚ â”‚
â”‚ â”‚                                                             â”‚ â”‚
â”‚ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â”‚
â”‚                                                                 â”‚
â”‚ ACCESS PROVISIONING BREAKDOWN                                  â”‚
â”‚ â–“â–“â–“â–“â–‘â–‘â–‘â–‘â–‘â–‘ 20% Already Open (3 datasets)                      â”‚
â”‚ â–“â–“â–“â–“â–“â–“â–“â–‘â–‘â–‘ 30% Ready to Grant (5 datasets)                    â”‚
â”‚ â–“â–“â–“â–“â–“â–“â–“â–“â–‘â–‘ 40% Needs Approval (6 datasets)                    â”‚
â”‚ â–“â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘ 10% Missing Location (1 dataset)                   â”‚
â”‚                                                                 â”‚
â”‚ ğŸ’¡ SMART SUGGESTION                                            â”‚
â”‚ â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”‚
â”‚ â”‚ Studies DCODE-001 and DCODE-088 are frequently bundled    â”‚ â”‚
â”‚ â”‚ with your selected datasets. Add them?                     â”‚ â”‚
â”‚ â”‚                                                             â”‚ â”‚
â”‚ â”‚ [Add Both] [View DCODE-001] [View DCODE-088] [Dismiss]    â”‚ â”‚
â”‚ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â”‚
â”‚                                                                 â”‚
â”‚ [View Detailed Breakdown] [Clear All] [Continue to Setup â†’]   â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

**User Actions:**
- Clicks **[View DCODE-088]** â†’ Reviews it â†’ Clicks **[Add Both]**
- Cart updates: 15 â†’ 17 datasets
- Access matrix recalculates automatically
- Notices one dataset (DCODE-299) is in 5 collections (high crossover)
- Clicks dataset in list â†’ Removes it
- Cart updates: 17 â†’ 16 datasets
- Access matrix recalculates again

**Final Selection:** 16 datasets

---

## Phase 6: Activities/Intents Selection

### UI Screen: Define Collection Purpose

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ Define Collection Purpose & Activities                          â”‚
â”‚â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”‚
â”‚                                                                  â”‚
â”‚ What will this data be used for?                                â”‚
â”‚ (This affects the access level users will receive)              â”‚
â”‚                                                                  â”‚
â”‚ â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â• â”‚
â”‚                                                                  â”‚
â”‚ DATA ENGINEERING                                                â”‚
â”‚ Select all that apply:                                          â”‚
â”‚                                                                  â”‚
â”‚ â˜ ETL/Standardization                                          â”‚
â”‚   â”” Activities: Date unification, unit harmonization (VAF %),  â”‚
â”‚     HGVS normalization, panel coverage mapping, LoD/LoQ         â”‚
â”‚     capture, QC flag propagation                                â”‚
â”‚   â”” Access Level: Processed/aggregated data                    â”‚
â”‚                                                                  â”‚
â”‚ â˜ Variant Harmonization                                        â”‚
â”‚   â”” Activities: Left-align/normalize, canonical transcript     â”‚
â”‚     selection, COSMIC/ClinVar annotation, deduplication         â”‚
â”‚   â”” Access Level: Genomic data preprocessing                   â”‚
â”‚                                                                  â”‚
â”‚ â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â• â”‚
â”‚                                                                  â”‚
â”‚ SCIENTIFIC ANALYSIS - Secondary use of patient level data      â”‚
â”‚ Select all that apply:                                          â”‚
â”‚                                                                  â”‚
â”‚ â˜‘ Early Response Classifier                                    â”‚
â”‚   â”” Analysis: Baseline ctDNA, % drop by Week 4, max VAF        â”‚
â”‚     using AI/ML models                                          â”‚
â”‚   â”” Access Level: Patient-level clinical + ctDNA data          â”‚
â”‚                                                                  â”‚
â”‚ â˜‘ Multimodal Fusion                                            â”‚
â”‚   â”” Analysis: ctDNA + PET MTV/TLG + clinical covariates        â”‚
â”‚     for integrated response prediction                          â”‚
â”‚   â”” Access Level: Patient-level multi-modal data               â”‚
â”‚                                                                  â”‚
â”‚ â˜‘ Cohort Builder                                               â”‚
â”‚   â”” Analysis: Filters for cancer type/subtype, stage, line,    â”‚
â”‚     regimen class, panel version                                â”‚
â”‚   â”” Access Level: Patient-level data for cohort creation       â”‚
â”‚                                                                  â”‚
â”‚ â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â• â”‚
â”‚                                                                  â”‚
â”‚ â„¹ï¸  Note: Scientific Analysis selections require patient-level â”‚
â”‚    data access and may require additional approvals.            â”‚
â”‚                                                                  â”‚
â”‚ [â† Back to Selection]              [Continue to User Setup â†’]  â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

**User Action:** Selects 3 Scientific Analysis options â†’ Clicks **[Continue to User Setup]**

---

## Phase 7: Collection Definition & User Assignment

### UI Screen: Collection Details

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ Collection Details & User Assignment                            â”‚
â”‚â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”‚
â”‚                                                                  â”‚
â”‚ COLLECTION INFORMATION                                          â”‚
â”‚                                                                  â”‚
â”‚ Collection Name *                                               â”‚
â”‚ â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”‚
â”‚ â”‚ Oncology ctDNA Outcomes Collection                         â”‚ â”‚
â”‚ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â”‚
â”‚                                                                  â”‚
â”‚ Description *                                                   â”‚
â”‚ â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”‚
â”‚ â”‚ Curated collection of Phase III lung cancer studies with   â”‚ â”‚
â”‚ â”‚ ctDNA biomarker monitoring and immunotherapy treatment     â”‚ â”‚
â”‚ â”‚ arms. Suitable for outcomes research, biomarker analysis,  â”‚ â”‚
â”‚ â”‚ and multimodal data fusion.                                â”‚ â”‚
â”‚ â”‚                                                             â”‚ â”‚
â”‚ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â”‚
â”‚                                                                  â”‚
â”‚ Target User Community                                           â”‚
â”‚ â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”‚
â”‚ â”‚ Oncology Data Scientists and Biostatisticians studying     â”‚ â”‚
â”‚ â”‚ immunotherapy response and ctDNA dynamics                  â”‚ â”‚
â”‚ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â”‚
â”‚                                                                  â”‚
â”‚ â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â• â”‚
â”‚                                                                  â”‚
â”‚ USER ASSIGNMENT                                                 â”‚
â”‚                                                                  â”‚
â”‚ [Organization-based â–¼] [Role-based] [Individual PRIDs]         â”‚
â”‚                                                                  â”‚
â”‚ â”Œâ”€ Organization-based (Workday) â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”‚
â”‚ â”‚                                                              â”‚ â”‚
â”‚ â”‚ Search organizations...  [Oncology_______________] [Search] â”‚ â”‚
â”‚ â”‚                                                              â”‚ â”‚
â”‚ â”‚ Selected Organizations:                                      â”‚ â”‚
â”‚ â”‚                                                              â”‚ â”‚
â”‚ â”‚ â˜‘ Oncology Biometrics (45 users)                           â”‚ â”‚
â”‚ â”‚   â”” Data Scientists (28), Biostatisticians (17)            â”‚ â”‚
â”‚ â”‚                                                              â”‚ â”‚
â”‚ â”‚ â˜‘ Oncology Data Science (60 users)                         â”‚ â”‚
â”‚ â”‚   â”” Data Scientists (42), Engineers (18)                   â”‚ â”‚
â”‚ â”‚                                                              â”‚ â”‚
â”‚ â”‚ â˜‘ Translational Medicine - Oncology (15 users)             â”‚ â”‚
â”‚ â”‚   â”” Scientists (12), Data Analysts (3)                     â”‚ â”‚
â”‚ â”‚                                                              â”‚ â”‚
â”‚ â”‚ [+ Add Organization]                                         â”‚ â”‚
â”‚ â”‚                                                              â”‚ â”‚
â”‚ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â”‚
â”‚                                                                  â”‚
â”‚ TOTAL TARGET USERS: 120 users                                  â”‚
â”‚                                                                  â”‚
â”‚ Filters (optional):                                             â”‚
â”‚ Role: [âœ“ Data Scientist] [âœ“ Biostatistician] [ ] Engineer     â”‚
â”‚ Training: Auto-filtered based on data requirements             â”‚
â”‚                                                                  â”‚
â”‚ â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â• â”‚
â”‚                                                                  â”‚
â”‚ [â† Back to Activities]          [Review Access Provisioning â†’] â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

**User Action:** Fills out form â†’ Clicks **[Review Access Provisioning]**

---

## Phase 8: Detailed Access Provisioning Breakdown

### UI Screen: Final Review Before Publishing

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ Access Provisioning Breakdown                            [Print]â”‚
â”‚â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”‚
â”‚                                                                  â”‚
â”‚ Collection: "Oncology ctDNA Outcomes"                           â”‚
â”‚ 16 datasets | 120 target users | 3 scientific analysis intents â”‚
â”‚                                                                  â”‚
â”‚ â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â• â”‚
â”‚                                                                  â”‚
â”‚ â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”â”‚
â”‚ â”‚ 20% ALREADY OPEN (for 50% of users)                         â”‚â”‚
â”‚ â”‚ â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘ â”‚â”‚
â”‚ â”‚                                                              â”‚â”‚
â”‚ â”‚ Status: âœ… No action needed                                  â”‚â”‚
â”‚ â”‚ Impact: 60 users (50%) have immediate access                â”‚â”‚
â”‚ â”‚ Details: Study closed, DB lock >6 months, no restrictions   â”‚â”‚
â”‚ â”‚                                                              â”‚â”‚
â”‚ â”‚ Datasets (3):                                                â”‚â”‚
â”‚ â”‚  â€¢ DCODE-001: NSCLC Genomic Profiling                       â”‚â”‚
â”‚ â”‚  â€¢ DCODE-023: Lung Cancer Survival Outcomes                 â”‚â”‚
â”‚ â”‚  â€¢ DCODE-045: Immunotherapy Response Study                  â”‚â”‚
â”‚ â”‚                                                              â”‚â”‚
â”‚ â”‚ [View Users with Access]                                     â”‚â”‚
â”‚ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜â”‚
â”‚                                                                  â”‚
â”‚ â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”â”‚
â”‚ â”‚ 30% READY TO GRANT (instant approval)                       â”‚â”‚
â”‚ â”‚ â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘ â”‚â”‚
â”‚ â”‚                                                              â”‚â”‚
â”‚ â”‚ Status: âš¡ One-click confirmation â†’ instant access to 90%   â”‚â”‚
â”‚ â”‚ Impact: 108 users (90%) will gain access                    â”‚â”‚
â”‚ â”‚ Timeline: ~1 hour after your confirmation                   â”‚â”‚
â”‚ â”‚ Details: Study closed, DB lock >6 months, no legal blocks   â”‚â”‚
â”‚ â”‚                                                              â”‚â”‚
â”‚ â”‚ Mechanism:                                                   â”‚â”‚
â”‚ â”‚  1. You click [Confirm Instant Grant] below                 â”‚â”‚
â”‚ â”‚  2. Collectoid updates Immuta policies (metadata only)      â”‚â”‚
â”‚ â”‚  3. Users automatically gain access within 1 hour           â”‚â”‚
â”‚ â”‚  4. Email notifications sent to users                       â”‚â”‚
â”‚ â”‚                                                              â”‚â”‚
â”‚ â”‚ Datasets (5):                                                â”‚â”‚
â”‚ â”‚  â€¢ DCODE-042: NSCLC ctDNA Monitoring                        â”‚â”‚
â”‚ â”‚  â€¢ DCODE-067: Immunotherapy Response Phase III              â”‚â”‚
â”‚ â”‚  â€¢ DCODE-088: Lung Cancer Clinical Outcomes                 â”‚â”‚
â”‚ â”‚  â€¢ DCODE-102: PET Imaging Substudy                          â”‚â”‚
â”‚ â”‚  â€¢ DCODE-134: Biomarker Validation Study                    â”‚â”‚
â”‚ â”‚                                                              â”‚â”‚
â”‚ â”‚ [View Affected Users] [View Immuta Policy Preview]          â”‚â”‚
â”‚ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜â”‚
â”‚                                                                  â”‚
â”‚ â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”â”‚
â”‚ â”‚ 40% BLOCKED - NEEDS APPROVAL (GPT/TALT)                     â”‚â”‚
â”‚ â”‚ â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘ â”‚â”‚
â”‚ â”‚                                                              â”‚â”‚
â”‚ â”‚ Status: ğŸŸ¡ Requires external approval from governance teams â”‚â”‚
â”‚ â”‚ Impact: 108 users (90%) after approvals complete            â”‚â”‚
â”‚ â”‚ Timeline: 2-5 business days depending on approval authority â”‚â”‚
â”‚ â”‚                                                              â”‚â”‚
â”‚ â”‚ Routing Details:                                             â”‚â”‚
â”‚ â”‚                                                              â”‚â”‚
â”‚ â”‚ â†’ GPT-Oncology (4 datasets) - Est. 2-3 days                â”‚â”‚
â”‚ â”‚   Reason: Active study data requires therapeutic area reviewâ”‚â”‚
â”‚ â”‚   â€¢ DCODE-156: Active NSCLC Trial                           â”‚â”‚
â”‚ â”‚   â€¢ DCODE-178: Ongoing Immunotherapy Study                  â”‚â”‚
â”‚ â”‚   â€¢ DCODE-189: Multi-Site Biomarker Trial                   â”‚â”‚
â”‚ â”‚   â€¢ DCODE-201: Phase III Active Study                       â”‚â”‚
â”‚ â”‚   Contact: Dr. Martinez (GPT-Oncology Lead)                 â”‚â”‚
â”‚ â”‚                                                              â”‚â”‚
â”‚ â”‚ â†’ TALT-Legal (2 datasets) - Est. 3-5 days                  â”‚â”‚
â”‚ â”‚   Reason: Cross-geography data (EU sites), GDPR review      â”‚â”‚
â”‚ â”‚   â€¢ DCODE-223: Multi-Regional Study (US + EU + Asia)        â”‚â”‚
â”‚ â”‚   â€¢ DCODE-267: European Consortium Study                    â”‚â”‚
â”‚ â”‚   Contact: Jane Smith (TALT-Legal)                          â”‚â”‚
â”‚ â”‚                                                              â”‚â”‚
â”‚ â”‚ What happens next:                                           â”‚â”‚
â”‚ â”‚  1. You click [Auto-Create Authorization Requests] below    â”‚â”‚
â”‚ â”‚  2. Collectoid creates formal approval requests             â”‚â”‚
â”‚ â”‚  3. Requests routed to GPT-Oncology and TALT-Legal          â”‚â”‚
â”‚ â”‚  4. Collectoid monitors approval status                     â”‚â”‚
â”‚ â”‚  5. Upon approval, Collectoid writes Immuta policies        â”‚â”‚
â”‚ â”‚  6. Users gain access automatically, notifications sent     â”‚â”‚
â”‚ â”‚                                                              â”‚â”‚
â”‚ â”‚ [View Approval Templates] [View Historical Approval Times]  â”‚â”‚
â”‚ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜â”‚
â”‚                                                                  â”‚
â”‚ â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”â”‚
â”‚ â”‚ 10% MISSING DATA LOCATION                                   â”‚â”‚
â”‚ â”‚ â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘ â”‚â”‚
â”‚ â”‚                                                              â”‚â”‚
â”‚ â”‚ Status: â“ Data not catalogued                               â”‚â”‚
â”‚ â”‚ Impact: Access delayed until data located and catalogued    â”‚â”‚
â”‚ â”‚ Timeline: Varies (depends on data discovery effort)         â”‚â”‚
â”‚ â”‚                                                              â”‚â”‚
â”‚ â”‚ Datasets (1):                                                â”‚â”‚
â”‚ â”‚  â€¢ DCODE-299: ctDNA Longitudinal Substudy                   â”‚â”‚
â”‚ â”‚    Issue: Metadata indicates study exists but S3 location   â”‚â”‚
â”‚ â”‚           not in current data catalog                       â”‚â”‚
â”‚ â”‚                                                              â”‚â”‚
â”‚ â”‚ What happens next:                                           â”‚â”‚
â”‚ â”‚  1. You click [Initiate Find/Catalogue Workflow] below      â”‚â”‚
â”‚ â”‚  2. Collectoid notifies data steward (Dr. Johnson)          â”‚â”‚
â”‚ â”‚  3. Manual search or data location verification begins      â”‚â”‚
â”‚ â”‚  4. Once located, standard provisioning workflow resumes    â”‚â”‚
â”‚ â”‚  5. You'll be notified when data is catalogued              â”‚â”‚
â”‚ â”‚                                                              â”‚â”‚
â”‚ â”‚ [Contact Data Steward] [View Similar Datasets]              â”‚â”‚
â”‚ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜â”‚
â”‚                                                                  â”‚
â”‚ â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”â”‚
â”‚ â”‚ 10% USERS HAVEN'T COMPLETED TRAINING                        â”‚â”‚
â”‚ â”‚ â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘ â”‚â”‚
â”‚ â”‚                                                              â”‚â”‚
â”‚ â”‚ Status: â³ Pending user training completion                  â”‚â”‚
â”‚ â”‚ Impact: 12 users (10%) currently blocked                    â”‚â”‚
â”‚ â”‚ Timeline: Depends on user completing required courses       â”‚â”‚
â”‚ â”‚                                                              â”‚â”‚
â”‚ â”‚ Training Requirements:                                       â”‚â”‚
â”‚ â”‚  â€¢ 8 users missing: GCP (Good Clinical Practice)            â”‚â”‚
â”‚ â”‚  â€¢ 4 users missing: Data Privacy Level 2 certification      â”‚â”‚
â”‚ â”‚                                                              â”‚â”‚
â”‚ â”‚ What happens next:                                           â”‚â”‚
â”‚ â”‚  1. You click [Send Training Reminders] below               â”‚â”‚
â”‚ â”‚  2. Collectoid sends email with training links to users     â”‚â”‚
â”‚ â”‚  3. System monitors training database for completion        â”‚â”‚
â”‚ â”‚  4. As soon as training completed, users automatically      â”‚â”‚
â”‚ â”‚     qualify for all unlocked data above                     â”‚â”‚
â”‚ â”‚  5. No additional DCM action needed                         â”‚â”‚
â”‚ â”‚                                                              â”‚â”‚
â”‚ â”‚ [View User List] [Send Training Reminders]                  â”‚â”‚
â”‚ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜â”‚
â”‚                                                                  â”‚
â”‚ â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â• â”‚
â”‚                                                                  â”‚
â”‚ ACTIONS                                                         â”‚
â”‚                                                                  â”‚
â”‚ â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”‚
â”‚ â”‚ Review your actions:                                        â”‚ â”‚
â”‚ â”‚                                                             â”‚ â”‚
â”‚ â”‚ â˜‘ Confirm instant grant for 30% (5 datasets, 108 users)   â”‚ â”‚
â”‚ â”‚ â˜‘ Create approval requests for 40% (6 datasets)           â”‚ â”‚
â”‚ â”‚ â˜‘ Initiate data discovery for 10% (1 dataset)             â”‚ â”‚
â”‚ â”‚ â˜‘ Send training reminders to users (12 users)             â”‚ â”‚
â”‚ â”‚                                                             â”‚ â”‚
â”‚ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â”‚
â”‚                                                                  â”‚
â”‚ [â† Back to Setup] [Export Report] [Publish Collection & Execute]â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

**User Action:** Reviews breakdown â†’ Clicks **[Publish Collection & Execute]**

---

## Phase 9: Collectoid Automation in Progress

### UI Screen: Publishing Progress

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ Publishing Collection...                                        â”‚
â”‚â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”‚
â”‚                                                                  â”‚
â”‚ âœ“ Collection "Oncology ctDNA Outcomes" Published               â”‚
â”‚                                                                  â”‚
â”‚ Collectoid is now executing your provisioning plan:             â”‚
â”‚                                                                  â”‚
â”‚ â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â• â”‚
â”‚                                                                  â”‚
â”‚ IMMEDIATE ACTIONS (Complete)                                    â”‚
â”‚ âœ“ Collection metadata saved to catalog                         â”‚
â”‚ âœ“ 60 users granted immediate access (20% - 3 datasets)         â”‚
â”‚ âœ“ Email notifications sent to users with immediate access      â”‚
â”‚                                                                  â”‚
â”‚ â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â• â”‚
â”‚                                                                  â”‚
â”‚ IN PROGRESS                                                     â”‚
â”‚                                                                  â”‚
â”‚ â³ Generating Immuta policies for instant grant                 â”‚
â”‚    â€¢ 5 datasets (30% category)                                  â”‚
â”‚    â€¢ 108 users will gain access                                 â”‚
â”‚    â€¢ Estimated completion: ~1 hour                              â”‚
â”‚    â€¢ Progress: â–“â–“â–“â–“â–“â–“â–“â–‘â–‘â–‘ 70% complete                         â”‚
â”‚                                                                  â”‚
â”‚ â³ Creating authorization requests for external approval        â”‚
â”‚    â€¢ 4 requests â†’ GPT-Oncology                                  â”‚
â”‚      â”” Est. approval: Nov 13-14 (2-3 business days)            â”‚
â”‚    â€¢ 2 requests â†’ TALT-Legal                                    â”‚
â”‚      â”” Est. approval: Nov 14-16 (3-5 business days)            â”‚
â”‚    â€¢ Collectoid will auto-grant upon approval                   â”‚
â”‚                                                                  â”‚
â”‚ â³ Initiating data discovery workflow                           â”‚
â”‚    â€¢ Dataset: DCODE-299                                         â”‚
â”‚    â€¢ Data steward notification sent to Dr. Johnson             â”‚
â”‚    â€¢ Manual search workflow started                             â”‚
â”‚    â€¢ You'll be notified when data is located                    â”‚
â”‚                                                                  â”‚
â”‚ â³ Training reminder emails sent                                â”‚
â”‚    â€¢ 12 users notified with training links                      â”‚
â”‚    â€¢ Auto-grant will trigger upon training completion           â”‚
â”‚    â€¢ No further DCM action needed                               â”‚
â”‚                                                                  â”‚
â”‚ â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â• â”‚
â”‚                                                                  â”‚
â”‚ PROGRESS TRACKING                                               â”‚
â”‚                                                                  â”‚
â”‚ Current Status: 60 of 120 users (50%) have some access         â”‚
â”‚ Expected: 108 users (90%) within 1 hour (instant grant)        â”‚
â”‚ Expected: 108 users (90%) within 3-5 days (after approvals)    â”‚
â”‚                                                                  â”‚
â”‚ [View Live Status Dashboard]                                    â”‚
â”‚ [Download Provisioning Report]                                  â”‚
â”‚ [Notify Users of Collection Availability]                       â”‚
â”‚ [Go to DCM Dashboard]                                           â”‚
â”‚                                                                  â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

**User Action:** Clicks **[Go to DCM Dashboard]**

---

## Phase 10: DCM Dashboard - Monitor Progress

### UI Screen: Collection Management Dashboard

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ Data Collection Manager Dashboard                       [Divya] â”‚
â”‚â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”‚
â”‚                                                                  â”‚
â”‚ [My Collections] [Approval Queue] [Issue Reports] [Analytics]  â”‚
â”‚                                                                  â”‚
â”‚ â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â• â”‚
â”‚                                                                  â”‚
â”‚ MY COLLECTIONS (8 active)                                       â”‚
â”‚                                                                  â”‚
â”‚ â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”â”‚
â”‚ â”‚ ğŸ†• Oncology ctDNA Outcomes Collection                       â”‚â”‚
â”‚ â”‚ Created: Nov 11, 2025, 14:30 | Status: âš¡ Provisioning     â”‚â”‚
â”‚ â”‚                                                              â”‚â”‚
â”‚ â”‚ Progress: â–“â–“â–“â–“â–“â–“â–‘â–‘â–‘â–‘ 60% Complete                          â”‚â”‚
â”‚ â”‚                                                              â”‚â”‚
â”‚ â”‚ TIMELINE                                                     â”‚â”‚
â”‚ â”‚ âœ“ Nov 11, 14:30 - Collection published                     â”‚â”‚
â”‚ â”‚ âœ“ Nov 11, 14:31 - 60 users granted immediate access (20%)  â”‚â”‚
â”‚ â”‚ â³ Nov 11, 15:30 - 108 users instant grant expected (30%)   â”‚â”‚
â”‚ â”‚ â³ Nov 13-14 - GPT-Oncology approvals expected (25%)        â”‚â”‚
â”‚ â”‚ â³ Nov 14-16 - TALT-Legal approvals expected (15%)          â”‚â”‚
â”‚ â”‚ â³ Pending - Data location discovery (10%)                  â”‚â”‚
â”‚ â”‚                                                              â”‚â”‚
â”‚ â”‚ CURRENT ACCESS                                               â”‚â”‚
â”‚ â”‚ 60 of 120 users (50%) have access to some/all datasets     â”‚â”‚
â”‚ â”‚ Target: 120 users (100%) with full collection access       â”‚â”‚
â”‚ â”‚                                                              â”‚â”‚
â”‚ â”‚ RECENT ACTIVITY                                              â”‚â”‚
â”‚ â”‚ â€¢ 2 min ago: Immuta policy generation in progress           â”‚â”‚
â”‚ â”‚ â€¢ 5 min ago: Authorization requests sent to GPT/TALT        â”‚â”‚
â”‚ â”‚ â€¢ 8 min ago: Training reminders sent to 12 users            â”‚â”‚
â”‚ â”‚                                                              â”‚â”‚
â”‚ â”‚ [View Detailed Status] [View Access Matrix] [Export Report] â”‚â”‚
â”‚ â”‚ [Send Update to Users] [Edit Collection]                    â”‚â”‚
â”‚ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜â”‚
â”‚                                                                  â”‚
â”‚ â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”â”‚
â”‚ â”‚ Cardiovascular Outcomes Collection                          â”‚â”‚
â”‚ â”‚ Created: Oct 28, 2025 | Status: âœ… Fully Provisioned       â”‚â”‚
â”‚ â”‚ 180 of 180 users (100%) have full access                   â”‚â”‚
â”‚ â”‚ [View Details] [View Analytics]                             â”‚â”‚
â”‚ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜â”‚
â”‚                                                                  â”‚
â”‚ [+ Create New Collection] [View All Collections]               â”‚
â”‚                                                                  â”‚
â”‚ â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â• â”‚
â”‚                                                                  â”‚
â”‚ APPROVAL QUEUE (12 pending)                                     â”‚
â”‚                                                                  â”‚
â”‚ ğŸŸ¢ 8 Auto-Approved by Collectoid (90/10 instant access)        â”‚
â”‚ ğŸŸ¡ 3 Routed for External Approval (GPT/TALT reviewing)         â”‚
â”‚ ğŸ”´ 1 Requires Your Review (edge case flagged)                  â”‚
â”‚                                                                  â”‚
â”‚ [View Approval Queue]                                           â”‚
â”‚                                                                  â”‚
â”‚ â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â• â”‚
â”‚                                                                  â”‚
â”‚ SYSTEM METRICS (Last 30 Days)                                   â”‚
â”‚                                                                  â”‚
â”‚ Requests Processed: 247                                         â”‚
â”‚ Auto-Approval Rate: 68% (â†‘ from 45% last month)                â”‚
â”‚ Average Approval Time: 2.1 days (â†“ from 12.5 days)             â”‚
â”‚ User Satisfaction: 4.3/5.0                                      â”‚
â”‚                                                                  â”‚
â”‚ [View Full Analytics] [Generate Report]                         â”‚
â”‚                                                                  â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

## Phase 11: Detailed Status View (Optional Deep Dive)

### UI Screen: Collection Progress Detail

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ Oncology ctDNA Outcomes Collection - Detailed Status           â”‚
â”‚â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”‚
â”‚                                                                  â”‚
â”‚ [Overview] [Access Matrix] [Timeline] [Activity Log] [Users]   â”‚
â”‚                                                                  â”‚
â”‚ â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â• â”‚
â”‚                                                                  â”‚
â”‚ DATASET-LEVEL STATUS (16 datasets)                              â”‚
â”‚                                                                  â”‚
â”‚ â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”â”‚
â”‚ â”‚ âœ… DCODE-001: NSCLC Genomic Profiling                       â”‚â”‚
â”‚ â”‚    Status: Accessible                                        â”‚â”‚
â”‚ â”‚    Users: 60 users have immediate access                    â”‚â”‚
â”‚ â”‚    Provisioned: Nov 11, 14:31                                â”‚â”‚
â”‚ â”‚    [View Users] [View Data]                                  â”‚â”‚
â”‚ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜â”‚
â”‚                                                                  â”‚
â”‚ â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”â”‚
â”‚ â”‚ â³ DCODE-042: NSCLC ctDNA Monitoring                        â”‚â”‚
â”‚ â”‚    Status: Provisioning (30% instant grant)                 â”‚â”‚
â”‚ â”‚    Timeline: Access available ~15:30 (1 hour from publish)  â”‚â”‚
â”‚ â”‚    Users: 108 users will gain access                        â”‚â”‚
â”‚ â”‚    Mechanism: Collectoid updating Immuta policy (70% done)  â”‚â”‚
â”‚ â”‚    [View Policy] [View Users]                                â”‚â”‚
â”‚ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜â”‚
â”‚                                                                  â”‚
â”‚ â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”â”‚
â”‚ â”‚ ğŸŸ¡ DCODE-156: Active NSCLC Trial                            â”‚â”‚
â”‚ â”‚    Status: Pending GPT-Oncology Approval                    â”‚â”‚
â”‚ â”‚    Timeline: Est. Nov 13-14 (2-3 business days)             â”‚â”‚
â”‚ â”‚    Reason: Active study data requires TA governance review  â”‚â”‚
â”‚ â”‚    Contact: Dr. Martinez (GPT-Oncology Lead)                â”‚â”‚
â”‚ â”‚    Users: 108 users pending approval                        â”‚â”‚
â”‚ â”‚    Next Steps: Collectoid monitoring approval status,       â”‚â”‚
â”‚ â”‚                will auto-grant upon approval                 â”‚â”‚
â”‚ â”‚    [View Authorization Request] [Contact Approver]           â”‚â”‚
â”‚ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜â”‚
â”‚                                                                  â”‚
â”‚ â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”â”‚
â”‚ â”‚ ğŸŸ¡ DCODE-223: Multi-Regional Study                          â”‚â”‚
â”‚ â”‚    Status: Pending TALT-Legal Approval                      â”‚â”‚
â”‚ â”‚    Timeline: Est. Nov 14-16 (3-5 business days)             â”‚â”‚
â”‚ â”‚    Reason: Cross-geography data (US+EU+Asia), GDPR review   â”‚â”‚
â”‚ â”‚    Contact: Jane Smith (TALT-Legal)                         â”‚â”‚
â”‚ â”‚    Users: 108 users pending approval (EU data only)         â”‚â”‚
â”‚ â”‚    Note: US and Asia data portions already accessible       â”‚â”‚
â”‚ â”‚    [View Authorization Request] [Contact Approver]           â”‚â”‚
â”‚ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜â”‚
â”‚                                                                  â”‚
â”‚ â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”â”‚
â”‚ â”‚ â“ DCODE-299: ctDNA Longitudinal Substudy                   â”‚â”‚
â”‚ â”‚    Status: Data Location Discovery in Progress              â”‚â”‚
â”‚ â”‚    Timeline: Unknown (depends on discovery effort)          â”‚â”‚
â”‚ â”‚    Issue: Metadata exists but S3 location not catalogued    â”‚â”‚
â”‚ â”‚    Activity:                                                 â”‚â”‚
â”‚ â”‚    â€¢ Data steward (Dr. Johnson) notified: Nov 11, 14:35     â”‚â”‚
â”‚ â”‚    â€¢ Manual search workflow initiated                        â”‚â”‚
â”‚ â”‚    â€¢ You'll be notified when data is located                 â”‚â”‚
â”‚ â”‚    [Contact Data Steward] [View Discovery Log]               â”‚â”‚
â”‚ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜â”‚
â”‚                                                                  â”‚
â”‚ [Load More Datasets (11 more)]                                  â”‚
â”‚                                                                  â”‚
â”‚ â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â• â”‚
â”‚                                                                  â”‚
â”‚ USER-LEVEL STATUS (120 users)                                   â”‚
â”‚                                                                  â”‚
â”‚ âœ… 60 users (50%): Have immediate access to 3 datasets         â”‚
â”‚ â³ 48 users (40%): Will gain access to 5 more datasets in ~1hr â”‚
â”‚ â³ 108 users (90%): Pending GPT/TALT approval for 6 datasets   â”‚
â”‚ â³ 12 users (10%): Blocked by missing training                  â”‚
â”‚                                                                  â”‚
â”‚ [View User Access Matrix] [Export User List] [Notify Users]    â”‚
â”‚                                                                  â”‚
â”‚ â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â• â”‚
â”‚                                                                  â”‚
â”‚ [â† Back to Dashboard] [Download Full Report] [Share Status]    â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

## Summary: Key Features Demonstrated

### 1. **AI-Assisted Discovery**
- Intent text input â†’ Keyword extraction
- Smart category suggestions from 30+ taxonomy
- Study count per category

### 2. **Multi-Dimensional Filtering**
- 4 filter dimensions (categories, study, collection, access)
- Live result count updates
- DCM-specific collection context filters

### 3. **Collection Crossover Analysis**
- Shows which collections contain each dataset
- Usage analytics (user counts, organizations)
- Smart bundling suggestions

### 4. **Progressive Refinement**
- Real-time access matrix updates
- Iterative selection (add/remove/adjust)
- Visual feedback on provisioning impact

### 5. **Activities/Intents Selection**
- Data engineering vs scientific analysis
- Affects access level granted
- Clear descriptions of each activity type

### 6. **Access Provisioning Breakdown (20/30/40/10)**
- Detailed visualization with progress bars
- Clear actions for each category
- Estimated timelines and contact information

### 7. **Collectoid Automation**
- Instant grant automation (30%)
- Authorization request creation and routing (40%)
- Progress monitoring and notifications
- Auto-grant upon approval

### 8. **Progress Tracking**
- Timeline view with estimated completion
- Dataset-level and user-level status
- Charts and analytics
- Export reports

---

## Estimated Build Time

**Phase Implementation Priority:**
1. Phase 2 (Category Suggestion) - 1 week
2. Phase 3 (Multi-Dimensional Filtering) - 1.5 weeks
3. Phase 5 (Selection Cart + Access Matrix) - 1 week
4. Phase 8 (Detailed Breakdown Viz) - 1 week
5. Phase 6 (Activities/Intents) - 0.5 weeks
6. Phase 7 (User Assignment) - 0.5 weeks
7. Phase 1, 9, 10 (Wrappers + Dashboard) - 1 week

**Total:** ~6.5 weeks for full DCM workbench

---

**End of DCM User Journey Mockup**
